InduPro
Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease
$77MSeries B
Role not disclosedS
Sanofi
Activity from announced rounds
Activity in this selectionOct 25, 2026 · North America · Jan 1, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $152M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionEarendil Labs
Earendil Labs develops protein therapeutics using AI models coupled with experimental antibody discovery and validation.
UndisclosedFinancing rounds disclosure
ParticipantAltesa BioSciences
Clinical-stage developer of oral antiviral medicines for people with chronic lung disease.
$75MSeries B
Role not disclosed